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Abstract: Background: This study aimed to examine the relationship between changes in systemic
vitamin B12 concentrations with pro-inflammatory cytokines, anthropometric factors and biochemical
markers of cardiometabolic risk in a Saudi population. Methods: A total of 364 subjects (224 children,
age: 12.99± 2.73 (mean± SD) years; BMI: 20.07± 4.92 kg/m2 and 140 adults, age: 41.87 ± 8.82 years;
BMI: 31.65 ± 5.77 kg/m2) were studied. Fasting blood, anthropometric and biochemical data were
collected. Serum cytokines were quantified using multiplex assay kits and B12 concentrations
were measured using immunoassay analyzer. Results: Vitamin B12 was negatively associated with
TNF-α (r = −0.14, p < 0.05), insulin (r = −0.230, p < 0.01) and HOMA-IR (r = −0.252, p < 0.01) in
all subjects. In children, vitamin B12 was negatively associated with serum resistin (r = −0.160,
p < 0.01), insulin (r = −0.248, p < 0.01), HOMA-IR (r = −0.261, p < 0.01). In adults, vitamin B12 was
negatively associated with TNF-α (r = −0.242, p < 0.01) while positively associated with resistin
(r = 0.248, p < 0.01). Serum resistin was the most significant predictor for circulating vitamin B12 in
all subjects (r2 = −0.17, p < 0.05) and in children (r2 = −0.167, p < 0.01) while HDL-cholesterol was
the predictor of B12 in adults (r2 = −0.78, p < 0.05). Conclusions: Serum vitamin B12 concentrations
were associated with pro-inflammatory cytokines and biochemical markers of cardiometabolic risks
in adults. Maintaining adequate vitamin B12 concentrations may lower inflammation-induced
cardiometabolic risk in the Saudi adult population.
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1. Introduction
Vitamin B12 is an essential micronutrient required for optimal hemopoetic, neurologic and
cardiometabolic function [1,2]. Human beings are dependent upon bacterial and protozoal sources to
maintain adequate serum concentrations [3]. Vitamin B12 absorption is a complex process and
any dysfunction can result in its deficiency, despite adequate dietary intake [4]. Vitamin B12
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deficiency affects two principal enzymatic pathways, i.e., methylation process of homocysteine to
methionine and the conversion of methylmalonyl coenzyme A (CoA) to succinyl-CoA [2,5], which
lead to accumulation of methylmalonic acid (MMA) and/or homocysteine (Hcy) [2,5]. Excessive
accumulation of homocysteine in blood (hyperhomocysteinemia) is associated with an increased
risk of cardiovascular disease due to its cellular and vasculo-toxic effects [1,5]; whilst, increase in
circualting methylmalonic acid (MMA) level is associated with defective fatty acid synthesis of neuronal
membranes [3,5].
Current evidence demonstrated that vitamin B12 deficiency is linked to various atherogenic
processes, mainly, but not exclusively, through B12 deficiency-induced hyperhomosyteinemia [6].
Hyperhomocysteinemia is a possible independent risk factor for cardiovascular disease, mechanisms
of which include reduction of nitric oxide thereby promoting endothelial dysfunction [7,8]. On the
other hand, cytokines, such as tumor necrosis factor (TNF-α) and resistin, play an important role in
cardiovascular risk and insulin resistance [9,10].
Unfortunately, there is limited information available as to whether circulating vitamin B12
concentrations affect the cardiometabolic status of the Arab population. In fact, while it has been
previously observed that vitamin B12 is inversely associated with homocysteine in the general Saudi
population [11], homocysteine itself is not a risk factor for endothelial function, at least amongst Saudi
Arabs [12]. Therefore, in this study we aimed to examine the associations between serum vitamin B12
concentrations, pro-inflammatory cytokines and biochemical markers of cardiovascular and metabolic
risk in the general population of Saudi Arabia.
2. Materials and Methods
2.1. Subjects and Experimental Design
In this cross-sectional study, a total of 364 Saudi subjects (224 children aged 8–17 years and
140 adults aged 30–59 years) were recruited from four Primary Health Care Centers (PHCCs) within
Riyadh, Saudi Arabia. Written informed consent was obtained prior to inclusion in the study.
Inclusion criteria were apparently healthy children (N = 224) and adults (N = 140), nonsmokers,
non-diabetic, non-hypertensive and without morbid obesity. Ethical approval was obtained from the
Ethics Committee of the College of Science Research Center (Ethics Approval Code: 8/25/36681),
King Saud University, Riyadh, Saudi Arabia.
2.2. Anthropometric Measurements
A generalized questionnaire was given to all participating subjects aimed at seeking demographic
information, general health status and past medical history. Physical examination was carried out
by a physician who ensured exclusion of subjects with chronic conditions (cardiac, kidney or liver
disease, hypertension, psychiatric conditions) or use of medications known to affect body weight
(e.g., steroids). Weight and height were recorded to the nearest 0.2 kg and 0.5 cm, respectively, using
an appropriate international standard scale (Digital Pearson Scale, ADAM Equipment Inc., Oxford, CT,
USA). Both measurements were done while subjects were standing upright and wearing light clothing.
Body mass index (BMI) was calculated as weight in kg divided by height in squared meters (kg/m2).
Additionally, waist and hip circumferences were measured using a standardized measuring tape in
centimeters (cm) and the waist-to-hip ratio (WHR) was estimated. Blood pressure was measured using
an appropriate mercury sphygmomanometer, measured twice with 5-min intervals and the mean of
the two readings was recorded.
2.3. Blood Collection and Biochemical Measurements
Fasting blood samples were collected and stored at −20 ◦C. Serum insulin, leptin, adiponectin,
TNF-α and resistin were quantified using multiplex assay kits that utilize fluorescent microbead
technology, allowing simultaneous quantification of several target proteins within a single serum
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sample of 50–100 µL. These included pre-mixed and fully customized panels that utilized the
Luminex’s xMAP Technology platform (Luminexcorp, TX, USA). For parameters measured using the
multiplex assay, the intra-assay variation was 1.4%–7.9% and inter-assay variation of <21%. Minimum
detectable concentrations (MDC) were as follows: insulin, 50.9 pg/mL; leptin, 85.4 pg/mL; adiponectin,
145.4 pg/mL; resistin, 6.7 pg/mL, and TNF-α, 0.14 pg/mL.
Vitamin B12 was measured using Roche Elecsys immunoassay analyzer, Cobas e 411
(Roche Diagnsotics GmbH, Mannheim, Germany) that employs the test principle of competitive
electrochemiluminiscence immunoassay. The assay has a linearity range of 30–2000 pg/mL. The assay
involves binding of vitamin B12 in the sample to the ruthenium labeled antibody. Streptavidin
coated microparticles (solid phase), binds the biotin labeled vitamin B12 and ruthenium labeled
antibody. A further wash period leaves the solid phase magnetic microparticles bound with vitamin
B12-biotin and ruthenium labeled antibody, which generates chemiluminiscent emission signal that is
inversely proportional to the concentration of vitamin B12 present in the patient sample. The inter-
and intra-assay coefficients of variation (CV) for Vitamin B12 were 3.0% and 3.7%, respectively.
Fasting serum glucose concentrations and complete lipid profile (triglycerides, total cholesterol,
high density lipoprotein (HDL)-cholesterol were determined using a biochemical analyzer) (Konelab,
Espoo, Finland). This biochemical analyzer was calibrated routinely prior to the analysis of all serum
samples using quality control samples provided by the manufacturer (Thermo-Fisher Scientific, Espoo,
Finland). Low density lipoprotein (LDL)-cholesterol was calculated using the Friedman formula.
2.4. Statistical Analyses
Statistical analyses were carried out using the SPSS software version 16.0 (SPSS Inc., Chicago,
IL, USA). Data were expressed as mean ± standard deviation. Kolmogorov-Smirnov statistics
was performed to test continuous variables for normality. All non-Gaussian parameters were
logarithmically or square-root transformed to normalize data. Independent Student T-test was used to
compare means between groups of normally distributed data. Pearson correlations between serum
vitamin B12 and the rest of the variables were determined. Stepwise linear regression models were
performed using vitamin B12 as dependent variable and age, gender, BMI, systolic and diastolic blood
pressure, waist and hip circumference, glucose, insulin, HDL, LDL, triglycerides, total cholesterol,
leptin, adiponectin, TNF-α, resistin, HOMA-IR as independent variables to determine significant
predictors. In all statistical tests, p-values < 0.05 were considered significant.
3. Results
A total of 364 Saudi subjects (224 children and 140 adults) satisfied the inclusion criteria and were
included in the analysis. All the anthropometric and laboratory characteristics of the study participants
are presented in Table 1.
Table 1. Clinical characteristics, glycemic, lipid and metabolic profiles of subjects.
Parameters Children Adults
Clinical Characteristics
N 224 140
M/F (%) 122/102 (54.5/45.5) 37/103 (26.4/73.6)
Age (years) 12.99 ± 2.73 41.87 ± 8.82
Body Mass Index (kg/m2) 20.07 ± 4.92 31.65 ± 5.77
Waist circumference (cm) 66.37 ± 15.50 88.51 ± 15.65
Hip circumference (cm) 82.06 ± 15.59 99.01 ± 15.77
Systolic Blood Pressure 105.54 ± 10.21 114.25 ± 13.53
Diastolic Blood Pressure 68.85 ± 7.12 75.73 ± 8.81
Glycemic Profile
Glucose (mmol/L) 5.11 ± 0.61 5.37 ± 0.81
Insulin (IU/mL) # 6.5 (4.1–10.8) 9.3 (7.1–13.2)
HOMA-IR # 1.46 (0.88–2.41) 2.37 (1.50–3.22)
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Table 1. Cont.
Parameters Children Adults
Lipid Profile
Triglycerides (mmol/L) # 1.06 ± 0.55 1.54 ± 0.71
Total Cholesterol (mmol/L) 4.23 ± 0.77 4.65 ± 0.98
HDL-Cholesterol (mmol/L) 1.02 ± 0.34 0.87 ± 0.33
LDL-Cholesterol (mmol/L) 2.72 ± 0.69 3.07 ± 0.77
Metabolic Profile
Leptin (ng/mL) # 9.10 (1.94–27.62) 15.73 (7.52–25.67)
Adiponectin (mg/mL) # 20.22 (12.66–28.42) 17.37 (5.19–431)
Resistin (ng/mL) # 15.10 (9.97–20.88) 5.01 (2.89–14.47)
TNF-α (pg/mL) # 7.51 (4.91–9.79) 15.34 (5.08–74.02)
Vitamin B12 (Pg/mL) # 421 (290.6–530.6) 371.25 (288.6–496.3)
Note: Data presented as N (%) for frequencies; mean ± standard deviation for normal continuous variables;
# denotes continuous variables with non-Gaussian distribution and presented as median (25th–75th Percentile).
Correlations between vitamin B12 and clinical parameters measured are presented in Table 2.
In children, vitamin B12 level was negatively associated with age (r =−0.19, p < 0.01), hip circumference
(r = −0.20, p < 0.01), systolic BP (r = −0.21, p < 0.01), insulin (r = −0.24, p < 0.01), HOMA-IR (r = −0.26,
p < 0.01) and resistin (r = −0.16, p < 0.01). In adults, vitamin B12 was positively associated with serum
resistin (r = 0.24, p < 0.01), whereas it was negatively associated with TNF-α (r = −0.24, p < 0.01). Mean
serum concentrations of vitamin B12 were plotted against quartiles of HOMA-IR (supplementary
materials Figure S1) and resistin (supplementary materials Figure S2) in children and adults.
Table 2. Associations between vitamin B12 and clinical, glycemic, lipid and metabolic profiles.
Parameters
Coefficients of Correlation (r)
Children (N = 224) Adults (N = 140)
Age (years) −0.192 ** 0.022
Body Mass Index (kg/m2) −0.132 0.006
Waist circumference (cm) −0.105 0.089
Hip circumference (cm) −0.207 ** 0.050
Systolic Blood Pressure (mmHg) −0.211 ** 0.116
Diastolic Blood Pressure (mmHg) −0.119 −0.029
Glucose (mmol/L) −0.102 −0.071
Insulin (IU/mL) # −0.248 ** −0.118
HOMA-IR −0.261 ** −0.156
Triglyceride (mmol/L) # −0.104 0.041
Cholesterol (mmol/L) 0.010 0.177
HDL-Cholesterol (mmol/L) 0.139 * 0.030
LDL-Cholesterol (mmol/L) −0.046 0.117
Leptin (ng/mL) # −0.130 0.060
Adiponectin (mg/mL) # 0.054 0.036
Resistin (ng/mL) # −0.160 ** 0.248 **
TNF-α (pg/mL) # −0.062 −0.242 **
Note: Data presented as coefficient (r); * denotes significance at 0.05 level; ** denotes significance at 0.01 level;
# log transformed values.
Stepwise linear regression analysis, using vitamin B12 as the dependent variable and all the
parameters as independent variables, is presented in Table 3. In adults, HDL-cholesterol was the
significant predictor of vitamin B12 (r2 = 0.78, p = 0.044) whilst, serum resistin (r2 = −0.16, p = 0.004),
gender (r2 = −0.15, p = 0.001) and age (r2 = −0.22, p = 0.02) were independent predictors of vitamin
B12 level in children.
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Table 3. Stepwise linear regression analysis using vitamin B12 as a dependent variable.
Predictor Unstandardized β SE p-Value
Adults HDL-cholesterol 0.781 0.169 0.044
Children
Gender −0.155 0.036 0.001
Age −0.022 0.007 0.02
Resistin −0.167 0.069 0.004
Note: Independent variables entered: age, gender, BMI, systolic and diastolic blood pressure, waist and
hip circumference, glucose, insulin, HDL-cholesterol, LDL-cholesterol, triglycerides, total cholesterol, leptin,
adiponectin, TNF-α, resistin, HOMA-IR. Significant at p < 0.05.
4. Discussion
The present study represents the first in a Saudi population and highlights a relationship between
circulating vitamin B12 concentrations, cytokines and biomarkers associated with cardiometabolic
risk. For this study we recruited a total of 364 subjects (224 children, and 140 adults). Fasting blood,
anthropometric and biochemical data were collected. Serum cytokines were quantified using multiplex
assay kits and B12 concentrations were measured using immunoassay analyzer. Our observations are
of considerable clinical importance, as any irregularity in the metabolism of vitamin B12 is known to
be associated with a wide spectrum of hematologic, metabolic and cardiovascular disorders and early
intervention appears key [1,4,5,9].
TNF-α is a hallmark of inflammation [13] and several lines of evidence suggest the association
of vitamin B12 deficiency with an increased incidence of inflammation and associated metabolic
complications [3,13]. In the current study we observed a significant inverse correlation between
serum vitamin B12 and TNF-α level in adults. However, in children, there was no such correlation.
Elevated systemic TNF-α level is observed to be associated with depletion of primary antioxidants
that cells use to protect themselves against free radicals’ damaging effects [14]. Depletion of
antioxidants further induces pro-inflammatory cytokines and other inflammatory by-products like
prostaglandins and leukotrienes, known risk factors for metabolic and cardiovascular diseases [14,15].
Earlier studies suggest that consistent chronic inflammation may lead to insulin resistance, type 2
diabetes mellitus (T2DM) and cardiovascular disease (CVD) [10]. Deficiency of vitamin B12 causes
hyperhomocysteinemia (HHcy) [5,16], and elevated homocysteine is known to lead to an inflammatory
state, a risk factor for coronary heart disease [16] and insulin resistance [17,18]. In mice, HHcy promotes
insulin resistance by directly inducing the expression and secretion of TNF-α and resistin [19]. TNF-α
then activates c-Jun N-terminal kinase (JNK), which, in turn, inhibits Akt activity and leads to insulin
resistance [20,21].
The study also observed an inverse association between vitamin B12, HOMA-IR and insulin
levels in children, indicating that deficiency of vitamin B12 at an early age may cause insulin resistance.
Consistent with our observation, a similar association between vitamin B12 and HOMA-IR was
observed by Mahalle et al. [1] and Kaya et al. [22], in Indian subjects with coronary artery disease and
in women with polycystic ovary syndrome, respectively. Furthermore, Stewart et al. found in Nepalese
subjects that low maternal vitamin B12 status was associated with insulin resistance in offspring [23].
Contrary to these, a cross-sectional study conducted in 135 Asian-Indian women found no correlation
between serum vitamin B12 and HOMA-IR [24].
Resistin, originally described as an adipocyte-specific hormone, has been suggested to be an
important link between obesity, insulin resistance and diabetes [25,26]. It was observed that serum
concentrations of resistin are significantly increased in obese and diabetic patients [27,28]. Resistin has
also been linked to the development of atherosclerosis and CVD [23,29]. In our study, a significant
inverse association between vitamin B12 concentrations and resistin was observed in children, whereas,
in adults, it was positively associated. Stepwise linear regression analysis revealed that resistin
was the most significant predictor of vitamin B12 in children. In another study, 220 patients with
acute coronary syndrome (ACS) had significantly higher serum resistin concentrations than patients
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classified as normal [30]. However, research on resistin has also been controversial in understanding
their pathological relevance and its association with T2DM and cardiovascular diseases [31,32]. Hence,
conclusive data await new strong evidence to elucidate the role of resistin in various disease processes.
Nevertheless, resistin has primarily been shown to be relevant to inflammation-related diseases
like atherosclerosis and arthritis [33] and may have a role in the regulation of pro-inflammatory
cytokines’ (IL-6 and TNF-α) expression in human peripheral blood mononuclear cells (PBMC) via
NF-κB pathway [33,34]. In yet another study conducted by Stejskal et al., it was observed that persons
with clinical signs of severe inflammation showed significantly higher concentrations of resistin than
healthy individuals [35]. Since resistin and TNF-α are pro-inflammatory in action, and inflammation
has a central role in cardiovascular diseases and insulin resistance, deficiency of vitamin B12 may,
therefore, have importance in the development of cardiometabolic diseases in Saudi population.
The limitations of this study include its cross-sectional nature and, thus, we cannot determine
causality. Furthermore, information on diet is lacking and would have provided added value as to
whether adequate B12 concentrations lead to better cardiometabolic parameters independent of a
healthy diet. Lastly, the findings may not be a true representation of the general healthy population,
since women were over represented in the current study, and whether the associations are true for those
with chronic diseases also cannot be answered in the study’s present scope. Despite these limitations,
this is the first study particularly from the Arab region, which reflects direct link between vitamin B12
with adipocytokines and biochemical markers of cardiometabolic risks. The present findings warrant
further investigation addressing how interventional therapies with vitamin B12 affect cardiovascular
and metabolic diseases.
5. Conclusions
In conclusion, our study suggests weak but significant associations between circulating vitamin
B12 concentrations with serum insulin and HOMA-IR in children, and inflammatory cytokines such as
TNF-α and resistin in adults. Our findings have significant clinical importance, since these biochemical
markers and cytokines are independent risk factors for cardiovascular and metabolic diseases in adults.
Thus, determination of vitamin B12 status and treatment in cases of deficiency could be a clinically
useful strategy in the prevention of cardiometabolic diseases.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/8/9/460/s1,
Figure S1: Mean vitamin B12 concentrations according to quartiles of HOMA-IR in children and adults, Figure S2:
Mean vitamin B12 concentrations according to quartiles of resistin in children and adults.
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